STS 2021 Online: Esophageal Surgery

The latest research in esophageal surgery, including esophagectomy as part of trimodality surgery and management of esophageal perforation.

*Unless otherwise noted, speakers have nothing to disclose.

Moderators

Douglas Liou

Digital Moderators

Maria Lucia Madariaga

Presentations:

1. Retrosternal Roux-en-Y esophagojejunostomy for delayed esophageal reconstruction without microvascular augmentation: A case series and comparison to gastric pull-up - Ilitch Diaz Gutierrez

2. Definition of Salvage Esophagectomy Influences Survival for Trimodality and Bimodality Therapy for Esophageal Squamous Cell Carcinoma - Nicolas Zhou

3. Clinical N3 Esophageal Cancer – Trimodality therapy vs. Definitive Chemoradiation - Monisha Sudarshan

4. Panel Discussion

5. A Large Series of Esophageal Perforation: Management and Outcomes - Andrea Axtell

6. Surgery after neoadjuvant chemoradiation therapy provides the best survival in octogenarians with esophageal cancer - Haydee del Calvo

7. Impact of Hospital Volume on Clinical and Financial Outcomes of Esophagectomy: Insights from the 2012-2017 National Inpatient Sample - Matthew Gandjian

8. Panel Discussion

Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Activity opens: 
03/01/2021
Activity expires: 
03/15/2024
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

The latest research in esophageal surgery, including esophagectomy as part of trimodality surgery and management of esophageal perforation.

*Unless otherwise noted, speakers have nothing to disclose.

Moderators

Douglas Liou

Digital Moderators

Maria Lucia Madariaga

Presentations:

1. Retrosternal Roux-en-Y esophagojejunostomy for delayed esophageal reconstruction without microvascular augmentation: A case series and comparison to gastric pull-up - Ilitch Diaz Gutierrez

2. Definition of Salvage Esophagectomy Influences Survival for Trimodality and Bimodality Therapy for Esophageal Squamous Cell Carcinoma - Nicolas Zhou

3. Clinical N3 Esophageal Cancer – Trimodality therapy vs. Definitive Chemoradiation - Monisha Sudarshan

4. Panel Discussion

5. A Large Series of Esophageal Perforation: Management and Outcomes - Andrea Axtell

6. Surgery after neoadjuvant chemoradiation therapy provides the best survival in octogenarians with esophageal cancer - Haydee del Calvo

7. Impact of Hospital Volume on Clinical and Financial Outcomes of Esophagectomy: Insights from the 2012-2017 National Inpatient Sample - Matthew Gandjian

8. Panel Discussion